Literature DB >> 8417779

Fumarate reductase activity of bovine heart succinate-ubiquinone reductase. New assay system and overall properties of the reaction.

V G Grivennikova1, E V Gavrikova, A A Timoshin, A D Vinogradov.   

Abstract

A simple system for aerobic assay of the quinol-fumarate reductase reaction catalyzed by purified soluble bovine heart succinate-ubiquinone reductase in the presence of NADH, NAD(P)H-quinone reductase (DT-diaphorase) and an appropriate quinone is described. The reaction is inhibited by carboxin, suggesting that the same quinone/quinol binding site is involved in electron transfer from succinate to ubiquinone and from ubiquinol to fumarate. The kinetic properties of the reaction in both directions and comparative affinities of the substrate binding sites of the enzyme to substrates (products) and competitive inhibitors are reported. Considerable difference in affinity of the substrates binding site to oxaloacetate was demonstrated when the enzyme was assayed in the direct and reverse directions. These results were taken to indicate that the oxidized dicarboxylate-free enzyme is an intermediate during the steady-state succinate-ubiquinone reductase reaction, whereas the reduced dicarboxylate-free enzyme is an intermediate of the steady-state ubiquinol-fumarate reductase reaction. No difference in the reactivity of the substrate-protected cysteine and arginine residues was found when the pseudo-first-order rate constants for N-ethylmaleimide and phenylglyoxal inhibition were determined for oxidized and quinol-reduced enzyme. Quinol-fumarate reductase activity was reconstituted from the soluble succinate dehydrogenase and low-molecular-mass ubiquinone reactivity conferring protein(s). No reduction of cytochrome b was observed in the presence of quinol generating system, whereas S-3 low temperature EPR-detectable iron-sulfur center was completely reduced by quinol under equilibrium (without fumarate) or steady-state (in the presence of fumarate). No significant reduction of ferredoxin type iron-sulfur centers was detected during the steady-state quinol-fumarate oxidoreductase reaction. The data obtained eliminate participation of cytochrome b in the quinol-fumarate reductase reaction and show that the rate limiting step of the overall reaction lies between iron-sulfur center S-3 and lower midpoint potential redox components of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417779     DOI: 10.1016/0005-2728(93)90067-p

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  Novel mitochondrial complex II isolated from Trypanosoma cruzi is composed of 12 peptides including a heterodimeric Ip subunit.

Authors:  Jorge Morales; Tatsushi Mogi; Shigeru Mineki; Eizo Takashima; Reiko Mineki; Hiroko Hirawake; Kimitoshi Sakamoto; Satoshi Omura; Kiyoshi Kita
Journal:  J Biol Chem       Date:  2009-01-02       Impact factor: 5.157

2.  Heterologous production in Wolinella succinogenes and characterization of the quinol:fumarate reductase enzymes from Helicobacter pylori and Campylobacter jejuni.

Authors:  Mauro Mileni; Fraser MacMillan; Christos Tziatzios; Klaus Zwicker; Alexander H Haas; Werner Mäntele; Jörg Simon; C Roy D Lancaster
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

3.  Kinetic model of mitochondrial Krebs cycle: unraveling the mechanism of salicylate hepatotoxic effects.

Authors:  Ekaterina Mogilevskaya; Oleg Demin; Igor Goryanin
Journal:  J Biol Phys       Date:  2006-10-26       Impact factor: 1.365

Review 4.  Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.

Authors:  Stephen J Ralph; Rafael Moreno-Sánchez; Jiri Neuzil; Sara Rodríguez-Enríquez
Journal:  Pharm Res       Date:  2011-08-24       Impact factor: 4.200

Review 5.  Expression and functional properties of fumarate reductase.

Authors:  J J Van Hellemond; A G Tielens
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS.

Authors:  Elena Maklashina; Sany Rajagukguk; T M Iverson; Gary Cecchini
Journal:  J Biol Chem       Date:  2018-04-02       Impact factor: 5.157

7.  Anaerobic expression of Escherichia coli succinate dehydrogenase: functional replacement of fumarate reductase in the respiratory chain during anaerobic growth.

Authors:  E Maklashina; D A Berthold; G Cecchini
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

8.  Mutation of the heme axial ligand of Escherichia coli succinate-quinone reductase: implications for heme ligation in mitochondrial complex II from yeast.

Authors:  Elena Maklashina; Sany Rajagukguk; William S McIntire; Gary Cecchini
Journal:  Biochim Biophys Acta       Date:  2010-01-25

9.  Crystallographic investigation of the ubiquinone binding site of respiratory Complex II and its inhibitors.

Authors:  Li-Shar Huang; Peter Lümmen; Edward A Berry
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2021-06-03       Impact factor: 4.125

10.  Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays.

Authors:  Vasily A Aleshin; Artem V Artiukhov; Henry Oppermann; Alexey V Kazantsev; Nikolay V Lukashev; Victoria I Bunik
Journal:  Cells       Date:  2015-08-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.